secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENDRA Life Sciences Inc. (NDRA)
CIK:        0001681682
Form:       8-K
Filed at:   2025-10-15T23:59:59+00:00
Accession:  0001654954-25-011797
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 1.02, 3.02, 5.08, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ENDRA raises $4.9M in private placement to launch digital asset treasury strategy managed by Arca
--------------------------------------------------------------------------------

- Gross proceeds of ~$4.9M from sale of 744,340 shares/prefunded warrants and warrants at $6.57 per unit; potential $14.4M if all warrants exercised.
- Majority of net proceeds to establish a digital asset treasury (DAT) investing in decentralized finance, starting with HYPE; managed by Arca Investment Management.
- Up to $1M of proceeds allocated for TAEUS pilot validation imaging study for MASLD/MASH; balance for working capital.
- Jeff Dorman, Arca's CIO, appointed to Digital Asset Advisory Board; ATM agreement with Ascendiant terminated.
- 2025 annual meeting set for Dec 9, 2025; record date Oct 16, 2025; stockholder proposal deadline Oct 27, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681682/000165495425011797/0001654954-25-011797-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681682/000165495425011797/endra_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-011797

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer